Agustín Arasanz Duque

: 21 mars 2024

Recherche partenariat En recherche de financements
A propos

Omica Biomed is at the forefront of biotechnology innovation, specializing in the research and development of cutting-edge genetic tests aimed at the early detection of cancer and rare diseases. Providing services to both the healthcare and veterinary sectors, we are committed to advancing diagnostic capabilities through precision medicine. Our pioneering liquid biopsy test for dogs enables the early detection of cancer, significantly enhancing treatment outcomes. Furthermore, our comprehensive genetic panel is meticulously designed to identify tumor types with unparalleled accuracy. At the heart of our innovation lies the OmiCareAI platform, a sophisticated AI-driven system that seamlessly integrates clinical, imaging, and genomic data. This integration not only improves the diagnostic process but also automates it, ensuring rapid, accurate, and personalized patient care. Omica Biomed is dedicated to transforming the future of diagnostics, bringing closer a world where early detection and tailored treatments become the standard across all sectors of health and veterinary care.

Mots clés et domaine d'activité:

 Santé et bien-être des animaux
 Ressources génétiques
 Soins de santé
 Garde d'enfants
 Équipement médical
 Innovation & Recherche
 Biotechnologie médicale
 Essais cliniques
 Intelligence artificielle

Idées proposées

Appels à projets suivis
Pas d'appels à projets suivis!